SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 78 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $11,000 | -87.1% | 1,527 | -78.4% | 0.00% | – |
| Q4 2020 | $85,000 | +400.0% | 7,082 | +267.7% | 0.00% | – |
| Q3 2020 | $17,000 | -57.5% | 1,926 | -42.1% | 0.00% | – |
| Q2 2020 | $40,000 | +33.3% | 3,325 | -24.4% | 0.00% | – |
| Q4 2019 | $30,000 | -6.2% | 4,400 | +44.6% | 0.00% | – |
| Q3 2019 | $32,000 | +18.5% | 3,043 | +2.5% | 0.00% | – |
| Q2 2019 | $27,000 | – | 2,969 | +11319.2% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 26 | -92.9% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 366 | +109.1% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 175 | +0.6% | 0.00% | – |
| Q2 2018 | $2,000 | – | 174 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,726,603 | $15,228,000 | 10.06% |
| Flagship Pioneering Inc. | 3,204,437 | $29,673,000 | 1.28% |
| Redmile Group, LLC | 3,620,376 | $33,525,000 | 0.95% |
| ARK Investment Management | 3,791,756 | $35,112,000 | 0.88% |
| Nikko Asset Management Americas, Inc. | 2,987,763 | $27,667,000 | 0.54% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,268,946 | $11,750,000 | 0.42% |
| 683 Capital Management, LLC | 429,775 | $3,980,000 | 0.36% |
| EcoR1 Capital, LLC | 248,480 | $2,301,000 | 0.23% |
| ALGERT GLOBAL LLC | 17,920 | $166,000 | 0.06% |
| Baker Brothers Advisors | 974,835 | $9,027,000 | 0.06% |